Cytomegalovirus Hyperimmune Globulin (CMV-Ig) Replacement in Hypogammaglobulinemic Lung Transplant Recipients

The Cleveland Clinic50 enrolled

Overview

This is a randomized controlled trial of CMV-Ig in lung transplant recipients at the Cleveland Clinic Foundation who are hypogammaglobulinemic.

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

PREVENTION

Masking

NONE

Enrollment

Drug: CMV-Ig

Sex: ALL

Medical Language ↔ Plain English

Inclusion Criteria: * Lung transplant * Hypogammaglobulinemia

Cleveland Clinic Foundation

Cleveland, Ohio, United States

CMV infection

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.